A Leading global pharmaceutical Contract Research Organization

Resources

SP Formulations stays ahead of current technologies to bring you the most advanced solutions. Our scientists' vast experience and aptitude in utilizing high-tech laboratory equipment offer an advantage over other contract laboratories. Our scientists have received the highest levels of training, and pass this knowledge on to our clients through careful guidance and collaboration.

White Papers

Challenging the drug development blueprint: A formulator's perspective

Semisolid Formulation Development: The CRO Approach

Freeze! Avoid Catastrophic Project Delays Caused by Formulation Changes

Brochures and Technical Briefs

SP Formulations Overview Brochure

Technical Brief - Formulation development for biologics - liquid and lyophilized formulations

Technical Brief - Formulation development for small molecules - liquid or lyophilized product

Technical Brief - Formulation development of topical semisolids

Technical Brief - Pharmaceutical solutions from The Smithers Group

Articles

The March issue of Transdermal Magazine featured the article Overcoming the Skin Barrier by Chemical Enhancements: A Formulator's Perspective, by Debanjan Das, John Augustine, Ph.D., and Marcel Langenauer, Ph.D.

Skin permeation and/or penetration enhancement is a daunting challenge for formulation scientists developing products for topical applications. From creating simple indications that treat acne to developing creams that deliver hormones for replacement therapy, overcoming the skin barrier has never been easy. Based on the indication, a formulator must develop a product that will carry bioactive molecules deep inside the skin, or even to the systemic circulation, using enhancers that can improve permeation and/or penetration but not interfere with the structural integrity of the skin. From a formulator's perspective, overcoming the skin barrier is definitely more than skin deep. Read the article.


 

 

 




For information on preclinical and clinical pharmaceutical analytical services, including GMP studies, visit our sister company,  Synomics Pharma.

Latest Synomics Pharma news:

WAREHAM, MA, USA – April 14, 2009 - Synomics Pharmaceutical Services, LLC, a leader in preclinical and clinical bioanalytical services, storage stability, and analytical testing services for the pharmaceutical industry, announced that the GPhA has named Synomics Pharma as a contract research organization member. For the full story, click here.

Click here to view information about all Smithers Group companies.